These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12647434)

  • 1. [Efficacy of selected antidepressants in senile depressive disorders--the author's own research].
    Łapin J; Bidzan L; Turczyński J; Sołtys K
    Psychiatr Pol; 2002; 36(6 Suppl):147-55. PubMed ID: 12647434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mirtazapine versus other antidepressive agents for depression].
    Knud Larsen J
    Ugeskr Laeger; 2012 Nov; 174(46):2864-6. PubMed ID: 23153468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effectiveness of newer and older antidepressants appears mediated by an age effect on the phenotypic expression of depression.
    Parker G
    Acta Psychiatr Scand; 2002 Sep; 106(3):168-70. PubMed ID: 12197852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of the efficacy of traditional antidepressive agents and the new generation of antidepressives in the treatment of depressive disorders].
    Cvjetković-Bosnjak M; Knezević A; Soldatović-Stajić B
    Med Pregl; 1999; 52(3-5):108-11. PubMed ID: 10518394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A controlled study of the efficacy and safety of mianserin and amitriptyline in depressive inpatients.
    Möller HJ; Kasper S; Müller H; Kissling W; Fuger J; Ruhrmann S
    Pharmacopsychiatry; 1995 Nov; 28(6):249-52. PubMed ID: 8773291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and tolerability of the new antidepressants.
    Nelson JC
    J Clin Psychiatry; 1997; 58 Suppl 6():26-31. PubMed ID: 9227670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressants.
    Frazer A
    J Clin Psychiatry; 1997; 58 Suppl 6():9-25. PubMed ID: 9227669
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.
    Leinonen E; Skarstein J; Behnke K; Agren H; Helsdingen JT
    Int Clin Psychopharmacol; 1999 Nov; 14(6):329-37. PubMed ID: 10565799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised, double-blind comparison of the efficacy and safety of citalopram compared to mianserin in elderly, depressed patients with or without mild to moderate dementia.
    Karlsson I; Godderis J; Augusto De Mendonça Lima C; Nygaard H; Simányi M; Taal M; Eglin M
    Int J Geriatr Psychiatry; 2000 Apr; 15(4):295-305. PubMed ID: 10767728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of mirtazapine in major depressive disorder patients after SSRI treatment failure: an open-label trial.
    Fava M; Dunner DL; Greist JH; Preskorn SH; Trivedi MH; Zajecka J; Cohen M
    J Clin Psychiatry; 2001 Jun; 62(6):413-20. PubMed ID: 11465517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Applications and safety of modern antidepressants in patients with liver diseases].
    Dubarek W; Kucia K
    Wiad Lek; 2007; 60(1-2):28-33. PubMed ID: 17607965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
    Malhi GS; Ng F; Berk M
    Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, randomized, group-comparative study of the tolerability and efficacy of 6 weeks' treatment with mirtazapine or fluoxetine in depressed Chinese patients.
    Hong CJ; Hu WH; Chen CC; Hsiao CC; Tsai SJ; Ruwe FJ
    J Clin Psychiatry; 2003 Aug; 64(8):921-6. PubMed ID: 12927007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of the clinical efficacy of mirtazapine.
    Benkert O; Muller M; Szegedi A
    Hum Psychopharmacol; 2002 Jun; 17 Suppl 1():S23-6. PubMed ID: 12404666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Care of depressed patients with anxiety symptoms.
    Nutt DJ
    J Clin Psychiatry; 1999; 60 Suppl 17():23-7; discussion 46-8. PubMed ID: 10446738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Mirtazapine-Fluoxetine Study Group.
    Wheatley DP; van Moffaert M; Timmerman L; Kremer CM
    J Clin Psychiatry; 1998 Jun; 59(6):306-12. PubMed ID: 9671343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New developments in the treatment of depression.
    Montgomery SA
    J Clin Psychiatry; 1999; 60 Suppl 14():10-5; discussion 31-5. PubMed ID: 10408420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression.
    Szegedi A; Müller MJ; Anghelescu I; Klawe C; Kohnen R; Benkert O
    J Clin Psychiatry; 2003 Apr; 64(4):413-20. PubMed ID: 12716243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The comparative studies of therapeutic results in patients with psychotic refractory depression treated with selected antidepressants and unilateral ECT].
    Hese RT; Gruszczyński W; Szwed A; Kielc M; Zalitacz M
    Psychiatr Pol; 2002; 36(6 Suppl):81-4. PubMed ID: 12647425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of antidepressants to treat depression in children and adolescents].
    Desombre H; Paccalin C; Revol O; Fourneret P
    Arch Pediatr; 2006 Jun; 13(6):711-3. PubMed ID: 16697608
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.